Biweekly oxaliplatin and irinotecan chemotherapy in advanced gastric cancer results in a median overall survival time of 9.5 months.

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.